Genedrive Plc (GDR.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -297 | -224 | -51 | 51 | 240 |
| Other Working Capital | -389 | 407 | 113 | -433 | -933 |
| Other Operating Activity | -4,458 | -3,951 | -3,867 | -4,212 | -4,459 |
| Operating Cash Flow | $-5,144 | $-3,768 | $-3,805 | $-4,594 | $-5,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -29 | -52 | -62 | -104 |
| Other Investing Activity | 43 | 30 | 44 | 91 | 105 |
| Investing Cash Flow | $20 | $1 | $-8 | $29 | $1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -358 |
| Common Stock Issued | 1,226 | 6,253 | 1,685 | 6,694 | 46 |
| Other Financing Activity | -108 | 111 | 139 | -119 | -144 |
| Financing Cash Flow | $1,118 | $6,364 | $1,824 | $6,575 | $-456 |
| Exchange Rate Effect | 0 | -10 | 1 | 5 | -37 |
| Beginning Cash Position | 5,188 | 2,601 | 4,589 | 2,574 | 8,218 |
| End Cash Position | 1,182 | 5,188 | 2,601 | 4,589 | 2,574 |
| Net Cash Flow | $-4,006 | $2,597 | $-1,989 | $2,010 | $-5,607 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,144 | -3,768 | -3,805 | -4,594 | -5,152 |
| Capital Expenditure | -23 | -29 | -52 | -62 | -104 |
| Free Cash Flow | -5,167 | -3,797 | -3,857 | -4,656 | -5,256 |